Literature DB >> 21162624

Combination adjuvants: the next generation of adjuvants?

George Mutwiri1, Volker Gerdts, Sylvia van Drunen Littel-van den Hurk, Gael Auray, Nelson Eng, Srinivas Garlapati, Lorne A Babiuk, Andrew Potter.   

Abstract

Adjuvants are critical components of many vaccines. The majority of existing vaccines contain a single adjuvant. Owing to their inherent limitations, no single adjuvant is capable of inducing all the protective immune responses required in the many different vaccines. Consequently, investigators are exploring the potential of using formulations with multiple adjuvants in a vaccine. An emerging paradigm is that careful selection of adjuvant combinations can result in complementary and even synergistic enhancement of immune responses to vaccines. This approach is promising and presents tremendous opportunities for vaccinologists to tailor immune responses to specific vaccines. In this article, adjuvant combinations at different stages of development will be reviewed.

Mesh:

Substances:

Year:  2011        PMID: 21162624     DOI: 10.1586/erv.10.154

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  23 in total

1.  Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.

Authors:  Angela Henderson; Katie Propst; Ross Kedl; Steven Dow
Journal:  Vaccine       Date:  2011-05-19       Impact factor: 3.641

2.  Designing a novel E2-IFN-γ fusion protein against CSFV by immunoinformatics and structural vaccinology approaches.

Authors:  Yanmin Zhang; Weijian Zhang; Jun Cheng; Xuping Liu; Shiwei Miao; Wen-Song Tan; Liang Zhao
Journal:  Appl Microbiol Biotechnol       Date:  2022-05-07       Impact factor: 4.813

3.  Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains.

Authors:  Janny Westdijk; Patrick Koedam; Mario Barro; Benjamin P Steil; Nicolas Collin; Thomas S Vedvick; Wilfried A M Bakker; Peter van der Ley; Gideon Kersten
Journal:  Vaccine       Date:  2013-01-09       Impact factor: 3.641

4.  Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.

Authors:  Alberto Fernández-Tejada; Eric K Chea; Constantine George; Jeffrey R Gardner; Philip O Livingston; Govind Ragupathi; Derek S Tan; David Y Gin
Journal:  Bioorg Med Chem       Date:  2014-09-17       Impact factor: 3.641

5.  Structure-Activity Relationship Studies To Identify Affinity Probes in Bis-aryl Sulfonamides That Prolong Immune Stimuli.

Authors:  Michael Chan; Fitzgerald S Lao; Paul J Chu; Jonathan Shpigelman; Shiyin Yao; Jason Nan; Fumi Sato-Kaneko; Vicky Li; Tomoko Hayashi; Maripat Corr; Dennis A Carson; Howard B Cottam; Nikunj M Shukla
Journal:  J Med Chem       Date:  2019-10-25       Impact factor: 7.446

Review 6.  Antibiotic alternatives: the substitution of antibiotics in animal husbandry?

Authors:  Guyue Cheng; Haihong Hao; Shuyu Xie; Xu Wang; Menghong Dai; Lingli Huang; Zonghui Yuan
Journal:  Front Microbiol       Date:  2014-05-13       Impact factor: 5.640

7.  A synthetic pathogen mimetic molecule induces a highly amplified synergistic immune response via activation of multiple signaling pathways.

Authors:  Naorem Nihesh; Saikat Manna; Bradley Studnitzer; Jingjing Shen; Aaron P Esser-Kahn
Journal:  Chem Sci       Date:  2021-04-01       Impact factor: 9.825

8.  The Adjuvants Polyphosphazene (PCEP) and a Combination of Curdlan Plus Leptin Promote a Th17-Type Immune Response to an Intramuscular Vaccine in Mice.

Authors:  Alyssa Chaffey; Glenn Hamonic; Dylan Chand; George K Mutwiri; Heather L Wilson
Journal:  Vaccines (Basel)       Date:  2021-05-14

Review 9.  Schistosome Vaccine Adjuvants in Preclinical and Clinical Research.

Authors:  Rachel Stephenson; Hong You; Donald P McManus; Istvan Toth
Journal:  Vaccines (Basel)       Date:  2014-09-02

10.  Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.

Authors:  Fateme Gableh; Mohsen Saeidi; Shaghayegh Hemati; Kasra Hamdi; Hoorieh Soleimanjahi; Ali Gorji; Amir Ghaemi
Journal:  J Biomed Sci       Date:  2016-01-25       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.